Explore more publications!
Illinois Tech Journal
Got News to Share?

Illinois Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on December 18, 2025

Elgin Cosmetic Dentist Outlines Smile Design Timeline
Dec. 18, 2025

Elgin Cosmetic Dentist Outlines Smile Design Timeline

Indeterminate EIN Presswire
Search Traffic Outperforms Social Discovery by Significant Margin: Blacksmith Agency
Dec. 18, 2025

Search Traffic Outperforms Social Discovery by Significant Margin: Blacksmith Agency

Indeterminate EIN Presswire
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Dec. 18, 2025

Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia

Indeterminate GlobeNewswire
Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended
Dec. 18, 2025

Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended

Indeterminate GlobeNewswire
Senti Biosciences Announces New Employment Inducement Grants
Dec. 18, 2025

Senti Biosciences Announces New Employment Inducement Grants

Indeterminate GlobeNewswire
TransAlta Provides Notice to Mothball Sheerness Unit 1
Dec. 18, 2025

TransAlta Provides Notice to Mothball Sheerness Unit 1

Indeterminate GlobeNewswire
Diginex Limited Executes Landmark Deal to Build Supply Chain Compliance Leader
Dec. 18, 2025

Diginex Limited Executes Landmark Deal to Build Supply Chain Compliance Leader

Indeterminate GlobeNewswire
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Dec. 18, 2025

Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec. 18, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Dec. 18, 2025

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Abivax to be Added to Nasdaq Biotechnology Index
Dec. 18, 2025

Abivax to be Added to Nasdaq Biotechnology Index

Indeterminate GlobeNewswire
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Dec. 18, 2025

vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
Dec. 18, 2025

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
Dec. 18, 2025

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors

Indeterminate GlobeNewswire
Applied Digital Sets Fiscal Second Quarter 2026 Conference Call for Wednesday, January 7, 2026, at 5:00 p.m. Eastern Time
Dec. 18, 2025

Applied Digital Sets Fiscal Second Quarter 2026 Conference Call for Wednesday, January 7, 2026, at 5:00 p.m. Eastern Time

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Dec. 18, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cue Biopharma Announces Proposed Public Offering
Dec. 18, 2025

Cue Biopharma Announces Proposed Public Offering

Indeterminate GlobeNewswire
Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes
Dec. 18, 2025

Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes

Indeterminate GlobeNewswire
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Dec. 18, 2025

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

Indeterminate GlobeNewswire
Qyrus Named a Leader in Autonomous Testing Platforms Evaluation by a Leading Industry Analyst Firm
Dec. 18, 2025

Qyrus Named a Leader in Autonomous Testing Platforms Evaluation by a Leading Industry Analyst Firm

Indeterminate EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions